Concepedia

Shih-Ting Tsao

ST

Statistics

Publications

8

Citations

256

H-Index

8

Active since

2012

Affiliations

Shenzhen Genoimmune Medical Institute(Current)

University of Florida

University of Electronic Science and Technology of China

Beijing Dao Pei Hospital

Capital Medical University

Shih-Ting Tsao is an author at Shenzhen Genoimmune Medical Institute specializing in cancer immunotherapy, immunology, and life sciences.

ORCID

Publications per year

2012–2024

8

Publications

8

HMG-CoA reductase inhibitors activate caspase-1 in human monocytes depending on ATP release and P2X7 activation

Yi-Hsiang Liao, Yi-Chieh Lin, Shih-Ting Tsao et al. · Journal of Leukocyte Biology · 2012 · 54 citations

, , +17

Functional Improvement of Chimeric Antigen Receptor Through Intrinsic Interleukin-15Rα Signaling

Sushmita Nair, Jingbo Wang, Shih-Ting Tsao et al. · Current Gene Therapy · 2018 · 47 citations

, , +17

GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma – assessing tumor and T cell interaction

Jatuporn Sujjitjoon, Elias Sayour, Shih-Ting Tsao et al. · Translational Oncology · 2020 · 35 citations · Full text

, , +17

Sequential allogeneic and autologous CAR-T–cell therapy to treat an immune-compromised leukemic patient

Jianping Zhang, Rui Zhang, Shih-Ting Tsao et al. · Blood Advances · 2018 · 33 citations · Full text

, , +16

Safety and Efficacy Evaluation of 4SCAR19 Chimeric Antigen Receptor-Modified T Cells Targeting B Cell Acute Lymphoblastic Leukemia - Three-Year Follow-up of a Multicenter Phase I/II Study

Lung‐Ji Chang, Lujia Dong, Yuchen Liu et al. · Blood · 2016 · 31 citations

, , +16

1–5 of 8